Concept: Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blocker (ARB) Prescriptions - Defined

Introduction

This concept describes how angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blocker (ARB) prescriptions are identified using administrative data in the MCHP Data Repository.

The primary use of ACE inhibitors and ARB prescriptions is to relax and enlarge the blood vessels in order to lower blood pressure. These drugs are sometimes prescribed for people with hypertension and diabetes.

Technical Definition of Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blocker (ARB) Prescriptions

The technical definition for defining angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blocker (ARB) prescriptions is as follows:


• Data Sources:
  
  • Drug Program Information Network (DPIN) data;
  
  
• Code Values and Conditions: - defined as Manitoba residents with the following drug prescriptions in a one-year period:
  
  
  • one or more prescriptions for angiotensin converting enzyme (ACE) Inhibitors - anatomical therapeutic chemical (ATC) drug classification system codes: C09A, C09B, OR
    
  • one or more prescriptions for angiotensin receptor blocker (ARB) - ATC codes: C09C, C09D